625 related articles for article (PubMed ID: 25879865)
1. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
2. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
4. Cognitive reserve and cortical thickness in preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Zhu Y; Wang MC; Brown T; Miller M; Albert M;
Brain Imaging Behav; 2017 Apr; 11(2):357-367. PubMed ID: 27544202
[TBL] [Abstract][Full Text] [Related]
5. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
6. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
7. APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
Tang X; Holland D; Dale AM; Miller MI;
J Alzheimers Dis; 2015; 47(3):645-60. PubMed ID: 26401700
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
9. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
10. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu T; Helm JL; Wierenga CE
Brain Imaging Behav; 2020 Apr; 14(2):369-382. PubMed ID: 32048144
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
[TBL] [Abstract][Full Text] [Related]
12. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
Tapiola T; Pennanen C; Tapiola M; Tervo S; Kivipelto M; Hänninen T; Pihlajamäki M; Laakso MP; Hallikainen M; Hämäläinen A; Vanhanen M; Helkala EL; Vanninen R; Nissinen A; Rossi R; Frisoni GB; Soininen H
Neurobiol Aging; 2008 Jan; 29(1):31-8. PubMed ID: 17097769
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
14. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
[TBL] [Abstract][Full Text] [Related]
15. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
[TBL] [Abstract][Full Text] [Related]
16. Brain atrophy rates in first degree relatives at risk for Alzheimer's.
Lampert EJ; Roy Choudhury K; Hostage CA; Rathakrishnan B; Weiner M; Petrella JR; Doraiswamy PM;
Neuroimage Clin; 2014; 6():340-6. PubMed ID: 25379448
[TBL] [Abstract][Full Text] [Related]
17. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
[TBL] [Abstract][Full Text] [Related]
18. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.
Geroldi C; Pihlajamäki M; Laakso MP; DeCarli C; Beltramello A; Bianchetti A; Soininen H; Trabucchi M; Frisoni GB
Neurology; 1999 Nov; 53(8):1825-32. PubMed ID: 10563634
[TBL] [Abstract][Full Text] [Related]
19. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
[TBL] [Abstract][Full Text] [Related]
20. Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Li S; Lu Y; Wang MC; Selnes OA; Moghekar A; O'Brien R; Albert M; The Biocard Research Team
Cogn Neurosci; 2013; 4(3-4):136-42. PubMed ID: 24168200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
